PDCD1 and gastric cancer: ICIs, which have shown remarkable potential as treatments for GC, primarily include programmed cell death ligand 1, programmed cell death protein 1 (PD-1), and cytotoxic T-lymphocyte antigen 4 inhibitors (6, 7).